Eli Lilly Wins Dismissal Of ERISA Fees Suit, Seeks Attorney Fees Over 1 Claim
INDIANAPOLIS — Arguing that one claim “was so clearly lacking in merit that deterrence against future, similarly meritless claims is appropriate,” pharmaceutical company Eli Lilly and Co. and related defendants who...To view the full article, register now.
Already a subscriber? Click here to view full article